The global veterinary vaccine adjuvants market is expected to grow at a CAGR of 5.5% during the forecast period, to reach USD 1.2 billion by 2030. The growth of this market is driven by the increasing demand for animal vaccines and growing awareness about animal health among consumers. The global veterinary vaccine adjuvants market has been segmented on the basis of type, application, and region. On the basis of type, it has been segmented into oral, subcutaneous and intramuscular adjuvants; on the basis of application it has been segmented into livestock vaccines and companion animals vaccines; while on the basis of region it has been segmented into North America, Latin America, Europe, Asia Pacific and Middle East & Africa regions. North America accounted for a major share in terms of revenue in 2017 owing to high adoption rates for animal vaccines in this region as well as high awareness about animal health among consumers in this region which drives demand for veterinary vaccine adjuvants from livestock producers. In addition to that Latin America is also expected to witness significant growth owing to increasing demand from livestock producers coupled with low cost production facilities available in this region which are driving up its share over time.
Some Of The Growth Factors Of This Market:
- Increasing awareness about animal welfare and safety is also expected to drive growth in this market over the forecast period as it will lead to increased adoption of preventive measures such as vaccination against diseases that can be transmitted from animals to humans or vice versa.
Industry Growth Insights published a new data on “Veterinary Vaccine Adjuvants Market”. The research report is titled “Veterinary Vaccine Adjuvants Market research by Types (Oral, Subcutaneous, Intramuscular, Others), By Applications (Livestock Vaccines, Companion Animals Vaccines), By Players/Companies SEPPIC, SDA BIO, Croda International Plc, SPI Pharma, MVP Laboratories, Zhuoyue, Zhiju Bio”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Veterinary Vaccine Adjuvants Market Research Report
By Type
Oral, Subcutaneous, Intramuscular, Others
By Application
Livestock Vaccines, Companion Animals Vaccines
By Companies
SEPPIC, SDA BIO, Croda International Plc, SPI Pharma, MVP Laboratories, Zhuoyue, Zhiju Bio
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
243
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Veterinary Vaccine Adjuvants Market Report Segments:
The global Veterinary Vaccine Adjuvants market is segmented on the basis of:
Types
Oral, Subcutaneous, Intramuscular, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Livestock Vaccines, Companion Animals Vaccines
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- SEPPIC
- SDA BIO
- Croda International Plc
- SPI Pharma
- MVP Laboratories
- Zhuoyue
- Zhiju Bio
Highlights of The Veterinary Vaccine Adjuvants Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oral
- Subcutaneous
- Intramuscular
- Others
- By Application:
- Livestock Vaccines
- Companion Animals Vaccines
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Veterinary Vaccine Adjuvants Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Veterinary vaccine adjuvants are substances that help increase the effectiveness of a vaccine. They can be added to the vaccine before it is given to a pet, or they can be administered after the pet has been vaccinated.
Some of the major companies in the veterinary vaccine adjuvants market are SEPPIC, SDA BIO, Croda International Plc, SPI Pharma, MVP Laboratories, Zhuoyue, Zhiju Bio.
The veterinary vaccine adjuvants market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Veterinary Vaccine Adjuvants Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Veterinary Vaccine Adjuvants Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Veterinary Vaccine Adjuvants Market - Supply Chain
4.5. Global Veterinary Vaccine Adjuvants Market Forecast
4.5.1. Veterinary Vaccine Adjuvants Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Veterinary Vaccine Adjuvants Market Size (000 Units) and Y-o-Y Growth
4.5.3. Veterinary Vaccine Adjuvants Market Absolute $ Opportunity
5. Global Veterinary Vaccine Adjuvants Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Veterinary Vaccine Adjuvants Market Size and Volume Forecast by Type
5.3.1. Oral
5.3.2. Subcutaneous
5.3.3. Intramuscular
5.3.4. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Veterinary Vaccine Adjuvants Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Veterinary Vaccine Adjuvants Market Size and Volume Forecast by Application
6.3.1. Livestock Vaccines
6.3.2. Companion Animals Vaccines
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Veterinary Vaccine Adjuvants Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Veterinary Vaccine Adjuvants Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Veterinary Vaccine Adjuvants Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Veterinary Vaccine Adjuvants Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Veterinary Vaccine Adjuvants Demand Share Forecast, 2019-2026
9. North America Veterinary Vaccine Adjuvants Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Veterinary Vaccine Adjuvants Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Veterinary Vaccine Adjuvants Market Size and Volume Forecast by Application
9.4.1. Livestock Vaccines
9.4.2. Companion Animals Vaccines
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Veterinary Vaccine Adjuvants Market Size and Volume Forecast by Type
9.7.1. Oral
9.7.2. Subcutaneous
9.7.3. Intramuscular
9.7.4. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Veterinary Vaccine Adjuvants Demand Share Forecast, 2019-2026
10. Latin America Veterinary Vaccine Adjuvants Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Veterinary Vaccine Adjuvants Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Veterinary Vaccine Adjuvants Market Size and Volume Forecast by Application
10.4.1. Livestock Vaccines
10.4.2. Companion Animals Vaccines
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Veterinary Vaccine Adjuvants Market Size and Volume Forecast by Type
10.7.1. Oral
10.7.2. Subcutaneous
10.7.3. Intramuscular
10.7.4. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Veterinary Vaccine Adjuvants Demand Share Forecast, 2019-2026
11. Europe Veterinary Vaccine Adjuvants Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Veterinary Vaccine Adjuvants Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Veterinary Vaccine Adjuvants Market Size and Volume Forecast by Application
11.4.1. Livestock Vaccines
11.4.2. Companion Animals Vaccines
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Veterinary Vaccine Adjuvants Market Size and Volume Forecast by Type
11.7.1. Oral
11.7.2. Subcutaneous
11.7.3. Intramuscular
11.7.4. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Veterinary Vaccine Adjuvants Demand Share, 2019-2026
12. Asia Pacific Veterinary Vaccine Adjuvants Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Veterinary Vaccine Adjuvants Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Veterinary Vaccine Adjuvants Market Size and Volume Forecast by Application
12.4.1. Livestock Vaccines
12.4.2. Companion Animals Vaccines
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Veterinary Vaccine Adjuvants Market Size and Volume Forecast by Type
12.7.1. Oral
12.7.2. Subcutaneous
12.7.3. Intramuscular
12.7.4. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Veterinary Vaccine Adjuvants Demand Share, 2019-2026
13. Middle East & Africa Veterinary Vaccine Adjuvants Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Veterinary Vaccine Adjuvants Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Veterinary Vaccine Adjuvants Market Size and Volume Forecast by Application
13.4.1. Livestock Vaccines
13.4.2. Companion Animals Vaccines
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Veterinary Vaccine Adjuvants Market Size and Volume Forecast by Type
13.7.1. Oral
13.7.2. Subcutaneous
13.7.3. Intramuscular
13.7.4. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Veterinary Vaccine Adjuvants Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Veterinary Vaccine Adjuvants Market: Market Share Analysis
14.2. Veterinary Vaccine Adjuvants Distributors and Customers
14.3. Veterinary Vaccine Adjuvants Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. SEPPIC
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. SDA BIO
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Croda International Plc
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. SPI Pharma
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. MVP Laboratories
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Zhuoyue
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Zhiju Bio
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook